These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4285956)

  • 21. [Regression and disappearance of bone metastasis in a case of prostatic carcinoma after bilateral orchidectomy and oestrogen therapy (author's transl)].
    Suhler A
    J Urol (Paris); 1981; 87(4):227-9. PubMed ID: 7264352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostatic cancer: indications for hormone therapy].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
    [No Abstract]   [Full Text] [Related]  

  • 23. Elevated free cortisol plasma levels in patients with prostatic carcinoma undergoing treatment with estrogens.
    Clerico A; Minervini R; Del Chicca MG; Barsantini S; Fiorentini L
    Int J Clin Pharmacol Res; 1984; 4(5):335-9. PubMed ID: 6097549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary report: determination of the pituitary ACTH reserve using metyrapone, based on the measurement of urinary levels of 11-desoxy-17, 21-dihydroxycorticosteroids (11-DOCS)].
    Ludwig G; Wajchenberg BL
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):165-9. PubMed ID: 4285347
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
    Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal therapy of prostatic cancer.
    Scott WW; Menon M; Walsh PC
    Cancer; 1980 Apr; 45(7 Suppl):1929-36. PubMed ID: 7370944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and therapy of prostatic carcinoma].
    Feustel A
    Z Urol Nephrol; 1973 Mar; 66(3):221-3. PubMed ID: 4577370
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of prostatic carcinoma].
    Kopper B; Lyding R
    Dtsch Med Wochenschr; 1977 Oct; 102(40):1423-6. PubMed ID: 71981
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormonal therapy in prostatic carcinoma.
    Resnick MI
    Urology; 1984 Nov; 24(5 Suppl):18-23. PubMed ID: 6388092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ovulation inhibitors and ACTH reserve].
    Rindt W; Heinen G; Oertel GW
    Endokrinologie; 1971 Apr; 57(3):358-63. PubMed ID: 4325995
    [No Abstract]   [Full Text] [Related]  

  • 31. [The ratio of various steroids in the urine of obese female patients following ACTH stimulation].
    Csillag M; Braun P; Gedeon A; Fehér GK; Vatai M
    Orv Hetil; 1965 Oct; 106(41):1940-2. PubMed ID: 4284854
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of prostatic cancer. The Finnish Academy and Duodecim].
    Duodecim; 1993; 109(19):1695-704. PubMed ID: 7736990
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aftereffects of long-time administration of ACTH on the function of the hypophyseal and adreno-cortical system in the guinea pig].
    Rentsch F
    Endokrinologie; 1965 Jun; 48(1):62-9. PubMed ID: 4285296
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of estrogen-resistant forms of cancer of the prostate].
    Marinbakh EB; Ar'e VM
    Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hormonal changes in carcinoma of the prostate].
    Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
    Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of ACTH reserve in pituitary-hypothalamic disease.
    De Witt GF; Abdullah F; Eravelly J; Selby R
    Med J Malaya; 1966 Jun; 20(4):276-80. PubMed ID: 4288690
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoma of the prostate. Clinical trial results. The Veterans Administration Co-operative Urological Research Group.
    Minn Med; 1971 Jul; 5(7):511-4. PubMed ID: 4935514
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer.
    Shearer RJ; Hendry WF; Sommerville IF; Fergusson JD
    Br J Urol; 1973 Dec; 45(6):668-77. PubMed ID: 4359746
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)].
    Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S
    Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of prostatic cancer].
    Lehtonen T; Mäntylä M
    Duodecim; 1979; 95(12):760-7. PubMed ID: 520197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.